Symposium - New York, United States
Over the past several years, cancer immunotherapy has made extraordinary progress both conceptually and in clinical practice. Led by landmark studies in the setting of metastatic melanoma, many of the findings of this field are being generalized both to hematological malignancies and to other solid tumors. Areas of investigation such as checkpoint blockade inhibitors, advanced tumor vaccination studies, and adoptive T-cell therapies are changing the face of cancer treatment. This symposium will bring together leading experts in immunotherapy and immunology to discuss these emerging approaches, along with the challenges and opportunities faced in this evolving field.
- Organization: New York Academy of Sciences
May 21, 2015 (9:00 AM - 5:00 AM ET)
7 World Trade Cetner
250 Greenwich st, New York, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
